Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The Times of Israel
TEVA stock on watch as CEO comments on opioid deal (NYSE:TEVA) | Seeking Alpha
Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & more